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Abstract: We present a new approach to distinguish between non-ergodic and ergodic behavior. Performing ensemble av-
eraging in a subpopulation of individual molecules leads to a mean value that can be similar to the mean value obtained in 
an ergodic system. The averaging is carried out by minimizing the variation between the sum of the temporal averaged 
mean square deviation of the simulated data with respect to the logarithmic scaling behavior of the subpopulation. For this 
reason, we first introduce a kind of Continuous Time Random Walks (CTRW), which we call Limited Continuous Time 
Random Walks (LCTRW) on fractal support. The random waiting time distributions are sampled at points which fulfill 
the condition N < 1, where N is the Poisson probability of finding a single molecule in the femtoliter-sized observation 
volume  V at the single-molecule level. Given a subpopulation of different single molecules of the same kind, the ratio T/ 
Tm between the measurement time T and the meaningful time Tm, which is the time for observing just one and the same 
single molecule, is the experimentally accessible quantity that allows to compare different molecule numbers in the sub-
population. In addition, the mean square displacement traveled by the molecule during the time t is determined by an up-
per limit of the geometric dimension of the living cell or its nucleus. 
Keywords: Anomalous motion, broken ergodicity, continuous time random walks (CTRW), continuous time random walks 
(CTRW) on fractal supports, Limited Continuous Time Random Walks (LCTRW) on fractal supports, molecular crowding, 
ergodicity, FCS, FCCS, fluorescence fluctuation microscopy, heterogeneity, living cells, complex body fluids like blood and its
components, interpretation of subdiffusive measurements, meaningful time for studying just one single molecule, physical 
model of crowding, physical model of temporal heterogeneity, random walks on fractal supports, resolution limits of measured 
diffusion times for two components, temporal autocorrelation, temporal two-color crosscorrelation, fluorescence imaging, time 
dependence of apparent diffusion coefficients. 
1. INTRODUCTION 
  Measurements of single-molecule fluctuations have a 
long history as an essential tool for studying diffusive and 
kinetic properties in confocal microscopy and spectroscopy 
[1]. For example, in dilute solutions fluctuations in the fluo-
rescence intensity are caused by fluctuations in the local 
concentration of fluorescent molecules. Fluorescence corre-
lation spectroscopy (FCS) measures the fluctuations of the 
collected fluorescence intensity from the time average value 
of the fluorescent species emitting photons at a certain value 
of wavelengths (emission peak maximum) in a laser-
illuminated observation volume  V. Moving on from time-
averaged ensemble measurements to studies on time-
averaged single enzyme molecules immobilized on cover 
slips allows for detection of dynamic disorder, i.e. time-
dependent fluctuations in the single-enzyme turnover [2-4]. 
  Enzymes and proteins in their natural environment of 
living cells or body fluids like blood and its components in-
teract with a network of numerous neighboring proteins, and 
their activity depends on the local environment and their role 
in the catalytic cycle [5]. As a consequence, the observed 
dynamic properties are related to the time since the system is 
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switched on (also called waiting time). This very slow phe-
nomenon is known as aging. One of the new developments 
concerns the breakdown of the fluctuation-dissipation theo-
rem [6] in subpopulations of single molecules. Theoretical 
arguments and some experimental data show that slow ap-
proaches to equilibrium influence fluctuations whose time 
scale is much shorter than the time for which the ensemble of 
single molecules shows non-stationary increments and gives 
rise to ergodicity breaking and aging [7, 8].  
  In recent years, evidence has accumulated for anomalous 
subdiffusive motion of molecules in various eukaryotic sys-
tems [7, 9, 10]. The eukaryotic cytoplasm contains different 
organelles, an elaborated cytoskeleton, and various mecha-
nisms for active transport of molecules in the cell and the 
cellular compartments like nucleus. Values of  ~ involve 
subdiffusion with  ~ < 1, normal diffusion with ~ = 1 as 
well as superdiffusive motion with  ~ > 1 suggesting the 
occurrence of active transport. In biological cells, the motion 
of proteins can be hindered either by molecular crowding 
or/and by chemical binding [7]. The important distinction 
being made by us is between space (structure)-dependent and 
time (rate)-dependent sources for anomalous diffusion [11]. 
The molecules are not immobilized on a solid support (solid 
phase) and they are not hydrodynamically or electrokineti-
cally focused. Fluorescence Molecule Counting for Single-Molecule Studies  Current Pharmaceutical Biotechnology, 2011, Vol. 12, No. 5    825
  In this original paper, we specifically address the ques-
tion of discriminating between spatial and temporal random-
ness that both lead to anomalous, subdiffusive motion of 
single molecules in living cells and their compartments like 
the nucleus or in body fluids like blood and its components.
We quantitatively describe the network of molecular interac-
tions of single molecules by the product      = ~ .   ac-
counts for the molecular crowding and  for the temporal 
heterogeneity. The paramete    controls the dynamics of the 
interaction network. In our computational model,   depends 
on the waiting time distribution of the single biomacro-
molecule to be trapped in interactions with its neighboring 
ligands or reaction partner(s). Unbroken and broken ergodic-
ity enter the problem by taking averages in the population of 
single molecules. A physical process is ergodic if the ensem-
ble average over many single molecule trajectories coincides 
the time average, i.e. a moving average over a single mole-
cule trajectory of time length T. Broken ergodicity means 
that both averages are different. In our case, using anomalous 
diffusion without broken ergodicity and anomalous diffusion 
with broken ergodicity would have the advantage of simulat-
ing experimentally accessible parameters like on-off events, 
diffusion times and apparent diffusion coefficients, respec-
tively, and temporal resolution limits of different single mo-
lecular species according to their mass differences [11]. As 
proven here for the first time, performing ensemble averag-
ing in a sparse subpopulation of such individual molecules 
during measurement leads to a mean value that can be simi-
lar to the mean value obtained in an ergodic system. Thus, 
broken ergodicity and unbroken ergodicity are not anymore 
distinguishable. In living cells or body fluids like blood and 
its components, ensemble and temporal averaging are carried 
out without knowing whether the underlying molecular sys-
tem behaves in ergodic or non-ergodic ways. Yet the theory 
predicts that each measurement can be related to an ergodic 
or a non-ergodic behavior unless one is able to show the sin-
gle-molecule fingerprint of non-ergodicity. 
2. THEORY 
  The essential ingredient of modeling the molecular 
crowding is the random walk of a molecule on fractal sup-
port that is taken as power law with a certain crowding ex-
ponent   [11]. Our choice was motivated by the presence 
of diffusive obstacles of many different sizes. These fractal 
supports have holes on every length scale due to their con-
struction procedure. Therefore, the diffusive motion of the 
molecule on such structures is slowed down at time t. The 
resulting diffusive law becomes subdiffusive [12] 
()
 
 t t t r    =
2   .   (1)
The mean square displacement (MSD) of the molecules 
() t r
2    in n-dimensional space is anomalous and scales with 
the crowding exponent  (0 <  < 1) [11].  
  If there is anomalous diffusive motion of molecules in a 
living cell due to a trap mechanism, then there must be some 
biological event that turns on the interaction with the traps. 
There are many possibilities for such an event [13]. Changes 
in localization like entry of a DNA-binding regulatory pro-
tein into the nucleus or assembly of a functional enzymatic 
complex or conformational changes in the diffusing species 
or binding of a ligand to a receptor or (de)phosphorylation 
can occur. We have first proposed an analysis concept in 
which diffusive motion is inherently linked to cellular me-
tabolism [11]. Our analysis concept differs from refs. [2-5, 7-
10, 12, 13] by its advantage to directly count the number of 
molecules in the femtoliter-sized observation/detection vol-
ume  V in the dilute solution or living cell. Hence, we refer 
to it as fluorescence molecule counting for single-molecule 
studies in the crowded environment and living cells. The 
determination of the molecule number per  V is used to fol-
low cell biological processes in time. One way that the single 
molecule can be probed in fluorescence molecule counting is 
by gathering the time dependent response as a time series 
measurement, e.g. a time-lapse measurement. In order to 
take account of temporal randomness of molecular interac-
tion, i.e. temporal heterogeneity, during subdiffusive motion 
of a single molecule, we perform the random walk on the 
fractal support as a continuous time random walk (CTRW) 
[11]. The MSD traveled by the molecule during the time t is 
given by the law  
()
   ~ 2 t t t r = 
  
.     (2)
  The important feature of this law (Eqn. 2) is that the spa-
tial and temporal coordinates are decoupled.  stands for the 
molecular crowding and   for the temporal randomness of a 
trapping mechanism. We quantitatively take both cellular 
restraints into account by the product     ~ =  .
  The molecule has to wait for a time t on each site of the 
fractal support before performing the next step. The waiting 
time is a random variable independently chosen at each new 
step according to a continuous distribution  () t  . In our case 
[11], the inverse gamma distribution was used to generate 
the waiting time steps  () () ()() ()()   
     =
+  +   1 1 1 t t e t
t ,
where () here is the gamma function. It is a well-known 
result that since the first moment is infinite the central limit 
theorem does not apply. The inverse gamma distribution was 
used because of the occurrence of heavy-tailed CTRW. 
Hence, it is very clear that the ergodicity is broken on all 
time scales t and we exactly simulated and predicted the be-
havior of a selfsame molecule in a crowded environment 
with temporal randomness [11, 14]. 
  Since the experimental conditions to measure a selfsame 
molecule over an extended period of time, at which biology 
is taken place, in living cells and body fluids like blood and 
its components or even in dilute solutions are very restrictive 
[14-17], temporal disorder can be mimicked through waiting 
time distributions  () t   displaying long-time tails  
() ()  
+  
1 t t   with  1 ~ , 0 < <   .               (3)
We need to perform the time average over a subpopulation 
of different single molecules of the same kind 
() () ()
T ens sub T ens sub ens sub T t n t r t r
  
= =
 ~ 2 2     . (4)
n here represents the diffusive steps of the single molecule. 
The two averaging procedures in Eqn. (4) are interchange-
able. Our experimental single-molecule regime given by 
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ing over the whole molecule ensemble suggested by Meroz, 
Sokolov, Klafter (2010) [7]. We perform averages in sparse 
subpopulations of single molecules, i.e. in sub-ensembles of 
single-molecules that are abbreviated by the subscript sub-
ens and the shorter sub for sub-population, respectively. 
  In this article, we shall examine the time and spatial de-
pendence of the heterogeneous exponents 
   ~ =   with  1 ~ , 0 < <    .    (5)
We present an approach on how to decide from a subset of 
single-molecule measurements how heterogeneous the stud-
ied system is in time. The single molecules are not immobi-
lized on a solid support and they are not hydrodynamically 
or electrokinetically focused. We theoretically describe the 
network of molecular interactions in living cells or body 
fluids like blood and its components by the product  ~. Thus, 
the important distinction is first made between space (struc-
ture)-dependent and time (rate)-dependent sources for 
anomalous diffusive motion.  
3. METHODS AND SIMULATION 
  Various experimental methods have been applied to 
large-scale studies of proteins and protein networks, includ-
ing mass spectrometry, protein chips, and two-hybrid screen-
ing [18-24]. Proteome studies using autofluorescent fusion 
proteins have also been performed [25]. These methods yield 
only qualitative data. The suitability of fluorescence correla-
tion spectroscopy for high-throughput data acquisition was 
shown [26]. There is a need for new techniques in order to 
quantify cellular protein networks. The first steps towards 
this goal include computational approaches and can experi-
mentally be performed by focusing on selected pathways. 
However, quantitative studies of protein-protein interaction 
networks are still in their infancy. Quantitative data from 
these in vitro interaction studies do not fulfill the require-
ments for standardization of the measurement conditions and 
they are of non-physiological nature due to the cell-free ap-
proaches. Therefore, we theoretically predict the collective 
influence of a molecular interaction network on the behavior 
of single biomacromolecules in living cells or body fluids 
like blood and its components or in dilute solution. The in-
fluence of the molecular interaction network is quantitatively 
expressed by the heterogeneity parameter  in Eqn. (5). 
  In Baumann and Földes-Papp 2010 [11], we have first 
established the most generally applicable method for data 
analysis of diffusive measurements in living cells or body 
fluids like blood and its components under crowded and het-
erogeneous conditions for two (dim = 2) or three (dim = 3) 
dimensions  
()
1 ~ ~
dim 2
 


=
  t t Dapp
      ( 6)
such that the MSD can then be written as 
() ()t t D t r app    = dim 2
2   .    (7)
 Here, 
  ~   is a pre-factor with dimensions of length-
squared per fractional time t. For the first time, specific ex-
amples of Eqs. (6) and (7) were theoretically analyzed in ref. 
[11]. Again, Eqs. (6) and (7) governing crowded and tempo-
rally heterogeneous motion of molecules at the many-
molecule and single-molecule levels give a complete picture 
concerning this subject. The existence of different exponents 
in Eqs. (6) and (7) is an important property of the prod-
uct ~of randomness in cellular systems and justifies the fol-
lowing concept: We first noted in ref. [11] that there is a 
normalized auto- (and two-color cross)correlation  ()  G  as-
sociated with Eqs. (6) and (7) 
() ( )
()
1 1 1 1
1
2 2 dim ~
2
1 ~
+  

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
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D D s N
G  ,   (8)
where   is the correlation time with  1
1
lim
0 + =
 N 
, N is the 
molecule number per femtoliter-sized observation volume 
 V at the many-molecule level or the Poisson probability of 
finding a single molecule in  V at the single-molecule level 
with N < 1 [14-17],   is the diffusion time that is a speci-
fied correlation time , and s here is a so-called structural 
factor that is defined, for instance, as  y x z s  =  0 with the 
half-length  0 z  and the radial waist  y x   of  V, dim = 3 for 
3D measurements and dim = 2 for 2D measurements in 
membranes. Time traces that are recorded for the subpopula-
tion of single molecules without interacting partner, e.g. 
without ligand, in the crowded environment of living cells 
and their cellular compartments, respectively, or body fluids 
like blood and its components yield    = ~ . The molecular 
crowding parameter   (0 <   < 1) can be measured in the 
absence of ligand(s) by means of Eq. (8) in fluorescence 
correlation spectroscopy. Knowing the molecular crowding 
parameter  for the cell type and cellular compartment type 
in the absence of ligand(s), the parameter of temporal het-
erogeneity  can be extracted from the measurements in the 
presence of interacting partner(s), e.g. ligand or neighboring 
protein(s), for the same   with  1 ~ , 0 < <   .   (Eqn. (5)) 
is not a simple fitting parameter. More specifically, one can 
inquire if spatial and temporal randomness in the single-
molecule trajectories can supply additional information use-
ful in discriminating between crowding and heterogeneous 
dynamic behavior of interactions with neighboring proteins 
or ligands in living cells or in body fluids like blood and its 
components. 
  If the molecular crowding is separated from temporal 
interaction rather than taking the usually non-separated form 
as a single dynamic exponent, then this view provides a 
straightforward explanation for the apparently different be-
havior of different classes of biomacromolecules like DNA, 
RNA, proteins in live cells and dextran molecules in solution 
ranging from 10 KDa to 2 MDa. So far, measurements in the 
literature only consider a single “dynamic” exponent, e.g. 
refs. [27-29, 9]. To our knowledge, experiments in living 
cells have never measured a value 0 <   < 1 solely due to 
molecular crowding; molecular interaction were always in-
volved to get 0 <   < 1. 
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 D app is the measured or apparent diffusion coefficient, 
e.g. in fluorescence correlation spectroscopy. m specifies 
one- (m = 1) or two-photon (m = 2) excitation. With this 
clarification, it would become more feasible to unambigu-
ously report mobility data in terms of either a time-
dependent diffusion time  D   or as time-dependent diffusion 
coefficient [30-33]. We do not discuss this subject here and 
refer to ref. [11].  
  We have applied random walks on fractal supports with-
out continuous waiting time distributions (so-called random 
walks on fractal structures, RWF) and with continuous wait-
ing time distributions (so-called continuous time random 
walks, CTRW) [34, 35]. Here, we give a brief summary how 
the simulations were carried out. For a more detailed discus-
sion, we refer to our papers [11] and [17]. We generate a 
random Brownian walk by randomly selecting steps in the 
three coordinate directions. The three coordinate directions 
are generated by a permutation of the vector v=(0,0,1) so that 
a set of orthogonal vectors S is generated. Mathematically 
this means we use the basic set of orthogonal unit vectors in 
a Cartesian coordinate system as the basis of our calcula-
tions. This set of permutated vectors is extended in all direc-
tions positive and negative by the following unification of 
basis sets. Introducing the random function  , which se-
lects the direction with equal probability randomly from our 
basis set S*, we create the Brownian track Bn() r r
   
, 0  by a sum 
of independent vectors.  0 r
 
 is the origin of the track of n-
steps represented as continuous function Bn() r r
   
, 0  for the end 
pointr
 
. The corresponding generating function is 
() 

= =
0 0, ,
n
n z r r z H
    Bn() r r
   
, 0 , which allows us to define the 
moments of the walk. This generation of a fractal is based on 
the renormalization of the whole structure and can be used 
efficiently to generate a fractal support on an infinite space. 
We perform random walks on these lattices. By the same 
method we generalized the Sierpinski gasket and the carpet 
to a different structure, if we not only delete one element in 
the generator but, instead, allow the deletion of more than 
one element. This, of course, results in a great variety of 
generalized Sierpinski patterns introducing a variation of the 
gasket and the carpet. In our examinations, we will restrict us 
to generalized Sierpinski carpets (GSC), which delete not 
more than half of the elements of the generator. We only 
supply the generator as input. The random walker is set on 
some site and it tests whether each site it arrives at is an al-
lowed site, as it goes along. This kind of walk generation is 
known as the blind ant approach. The actual procedure is as 
follows: The walk can start at any site of the underlying vir-
tual lattice. To check whether a site is accessible, the first 
step is to identify the iteration stage the point belongs to. For 
any 
3  grid, a point having either an x
(i)-coordinate (i = 1, 2, 
3) between 
1  k   and 
k  belongs to the kth iteration stage of 
the fractal. In the kth-stage coarse-grained pattern with units 
of size  , it is checked whether the block containing the 
site matches an accessible site on the given generator. If 
found accessible, the corresponding point in the next lower 
stage, i.e. ), is ascertained. In this way, the point is 
successively scaled down until it reaches the first stage. In 
general, in the kth stage, the equivalent coordinates 
() () () ()
3 2 1 , , k k k x x x  are given by the integer parts of  () 1  k i
k x   with 
i = 1,2,3. If  () () () ()
3 2 1 , , k k k x x x  matches an allowed site, the coor-
dinates carried over to the next stage are 
() () ( )
1
1 , mod

 =
k i
k
i
k x x  ; i = 1,2,3. If an equivalent coordinate of 
any stage does not match the list of accessible sites, the site 
under consideration is blocked, only those sites surviving up 
to stage 1 are accessible. If the point corresponds to a 
blocked site, at any stage of the process, it is inaccessible. 
This procedure of coarse graining the grid corresponds to a 
renormalization of the lattice. The steps discussed generate 
an ordinary Brownian walk on a fractal support using a con-
stant time step. In a continuous time random walk (CTRW), 
the molecule has to wait for a time t on each site of the frac-
tal before performing the next step. This waiting time is a 
random variable independently chosen at each new step ac-
cording to a continuous distribution  () t  . In our case, it is a 
stable Levy distribution. If in addition to the walk on a frac-
tal support we vary the time step based on a waiting time 
distribution, in our simulations an inverse gamma distribu-
tion, we generate a CTRW on a fractal support. For more 
details on the simulation of CTRW we refer to [11]. 
4. RESULTS AND DISCUSSION 
  The amount of irregularity in molecule trajectories of 
dynamic systems of living cells or body fluids like blood and 
its components can be quantified in various ways. From a 
mathematical point of view, the anomalous exponents  ~
measure the dependence of the future behavior on small 
changes in the systems' initial conditions. When the dynamic 
behavior is independent of the initial conditions, the associ-
ated single molecule trajectories are ergodic [6]. The single 
molecule trajectories are said to be non-ergodic when the 
dynamics depend on the initial conditions.  
  Let us assume that we have measurement data for the 
mean square displacement (MSD) based on time averages 
extracted from non-ergodic systems. Then, we can ask the 
following question. How many of these infinite tracks are 
needed to get the same scaling exponent resulting from the 
sample average of an ergodic system. The practical impor-
tance of this question is related to the experiments carried 
out with living cells to distinguish ergodic from non-ergodic 
behavior. Our results show that a selection of a few non-
ergodic tracks allows us to represent in the mean of non-
ergodic measurements the same scaling behavior as in er-
godic systems. This means that in real experiments it be-
comes evidently very difficult to distinguish ergodicity from 
broken ergodicity from a practical point of view. To formu-
late the problem precisely let us denote the set of data by 
() () ( ) () [] {} b a t t f t S t f t S i i i i i , | , , ~ ~  = =       with  …  , 3 , 2 , 1 =  , (10)
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where a and b are the lower and upper bounds of the tempo-
ral measurement interval. If this data set represents meas-
urement points for anomalous, subdiffusive processes we 
know that the MSD based on a temporal average is given by 
()

 


~
~ t t f MSDT   = =  with  …  , 3 , 2 , 1 =  ,   (11)
where   counts the single-molecule tracks. Assuming that 
the number of single-molecule tracks  out of an infinite set 
of possible outcomes in a non-ergodic system can be ordered 
as      + =    ~ ~ ~
min  with  () max min max
~ ~ ~      =  , we 
introduce the following averaging over non-ergodic single-
molecule tracks . The averaging is carried out by minimiz-
ing the variation between the sum of the temporal averaged 
MSD data with respect to the logarithmic scaling behavior of 
the subpopulation. This yields the least possible variation 
over non-ergodic single-molecule tracks 
() () ( ) sub sub sub i sub i c c t t f , ~ ~ 1
log min
2
1 max
max
   


	






+   

	

 




=


 
 . (12)
  Eqn. (12) represents nothing more than a minimization of 
the squares of the errors, e.g. measurement errors. Meaning 
that we are deriving the characteristics of the sub-population 
sub  ~  and  sub c  by an minimization of the mean square de-
viation of the simulated data and the predicted model in a 
logarithmic representation. 
sub  ~  represents the “averaged” 
scaling exponent, while  sub c  is related to the pre-factor of 
the scaling law. To achieve the agreement between the sam-
ple MSD,  ~  and the average defined in Eqn. (12), we have 
in addition to minimize the variation between the experimen-
tal scaling exponent  ~  and the sub-population scaling expo-
nent 
sub  ~
max min
~ ~ ~ ~ ~ min        

	 


 
sub sub with   (13)
  This way of minimizing the variations allows us not only 
to derive bounds for the scaling exponents 
sub  ~  in the 
subpopulation of single molecules as  [] max min
~ , ~ ~    
sub
but moreover to fix the number of single-molecule tracks in 
the subpopulation as 
max  N . It turns out that the optimal 
number of tracks 
max  N  is a small number taken from an 
infinite set of possible values  ~ . In Fig. (1), the global min-
ima occurring in this minimization process of single-
molecule variations are shown for the simulated scaling ex-
ponent  ~ = 0.689. The bounds for  ~  are given in general by 
Eqs. (12) and (13). Fig. (1) shows how the simulated scaling 
behavior of the exponent  ~  changes in a subpopulation of 
simulated single-molecule variations. The curves in Fig. (1)
represent the variation of the simulated scaling exponent 
compared with the sub-population exponent 
sub  ~  if the 
number of simulated tracks included in the optimization (12) 
changes. The different curves are related to the maximal 
scaling exponent  max
~  taken from the set 
{ } 8 . 0 . 799 . 0 , 797 . 0 , 795 . 0 , 785 . 0 ~
max =  . These values are a re-
sult of the simulations published in ref. [11]. The values 
max
~  are assigned to the curves from top to bottom and, re-
spectively, they are selected at the far right side of the Fig. 
(1) from top to bottom. 
  The global minima of 
sub  ~  are determined under the 
constraint of Eqn. (13), i.e.  max min
~ ~ ~     
sub  . 
The minimization of 
sub   ~ ~   is carried out under the 
constraint that the lower and upper boundary of the  ~ -
values are unknown. These variations of the interval 
[] max min
~ , ~    are determined by the minimization of Eqn. 
(13). The resulting intervals of the minimization of Eqn. (13) 
under the change of  ~  itself are shown in Fig. (2). The 
global minima of the variations are determined by  ~  as 
shown in Fig. (2). We depict an example of averaging and 
the resulting scaling behavior of the  ~ -interval [] max min
~ , ~  
in subpopulations of biomacromolecules for the chosen 
simulated value  ~  = 0.689 of Eqn. (5). Boundary values 
[] max min
~ , ~    of dynamically distinct regions change with 
different simulated ~ values. The  ~ -interval [] max min
~ , ~    for 
single-molecule tracks in a subpopulation shows a certain 
bandwidth. Only within that bandwidth, variations of single-
molecule responses are possible. Thus, we are able to charac-
terize the response pattern of single-molecule variations by 
the heterogeneity parameter , which is modulated by the 
network of interactions.   is experimentally accessible by 
means of fluorescence correlations spectroscopy and two-
color fluorescence crosscorrelation spectroscopy. The dy-
namic interaction and cellular function of a cellular protein is 
modulated by up to 100 different proteins at different sites in 
the cell [18-24]. The spatio-temporal organization is 
achieved by cellular networks that we characterize by their 
temporal heterogeneity  .
 Fig.  (3) shows an ensemble of 32 randomly selected sin-
gle-molecule tracks represented as dots. These tracks are the 
basis of the determination of 
sub  ~  based on the minimiza-
tion processes (12) and (13). Each of these tracks shows a 
specific scaling exponent which is combined in the minimi-
zation to a common scaling exponent. The most striking fea-
ture of performing ensemble averaging in sparse subpopula-
tions of single molecules, however, is a mean value
sub  ~  of 
the solid green line in Fig. (3) that is the same mean value 
obtained in an ergodic system. Hence, broken ergodicity and 
unbroken ergodicity are not anymore distinguishable. In ad-
dition, when averaging procedures are carried out withoutFluorescence Molecule Counting for Single-Molecule Studies  Current Pharmaceutical Biotechnology, 2011, Vol. 12, No. 5    829
Fig. (1). The minima of the variations 
sub   ~ ~   are shown as a function of the number of single molecule tracks   N . In these graphs, 
the lower bound  min
~   is fixed to the value  min
~  =0.243 representing the optimal choice for the experimental  ~ = 0.689. The curves are as-
signed to the upper bounds of  ~  from top to bottom. On the right side of the figure we have  { } 8 . 0 . 799 . 0 , 797 . 0 , 795 . 0 , 785 . 0 ~
max =  . We 
identify that for a given  ~ = 0.689 the interval for selecting the random number of single-molecule tracks from the total ensemble of single-
molecule macromolecules in the subpopulation (the total ensemble of single-molecule tracks) should range from [] max min
~ , ~    = [0.243, 
0.799]; for this range  [] max min
~ , ~ ~    
sub
, we find the minimal variation if the number of randomly selected single-molecule tracks is 
max  N =
32. All other values of   N  deliver only a local minimum instead of a global minimum. The graphs also show that the variation approaches a 
stable value if   N  approaches large values; i.e. only a small subpopulation of single molecules delivers the minimal variation.  
Fig. (2).  The variation of the  ~ -interval [] max min
~ , ~    with respect to the MSD scaling behavior  ~   in the optimization process for deriving 
sub  ~ by using Eqs. (12) and (13). In the graph we can distinguish different domains for ~ . The first domain ranges from 
… 392 . 0 ~ 0 < <   allowing a fixed interval for the limits [] max min
~ , ~    = [0, 1/2]. For values  … … 878 . 0 ~ 392 . 0 < <  , we observe a highly 
structured set of intervals where the upper and lower limit reaches some minimal or maximal value and allows the whole range [0, 1] for spe-
cific values. The optimal number of tracks is for both  ~ -intervals equal to 32. For the last interval  1 ~ 878 . 0 < <  … , we observe the maxi-
mal value  1 ~
max    while the lower limit  min
~   varies between  2 1 ~ 0 min < <  . For this last domain of  ~ , the number of tracks decreases 
to a smaller value 
max  N < 32. The resolution in  ~ to derive the shown plot was  =  ~ 0.00078125.  

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Fig. (3).  The graph shows a random selection of 
max  N = 32 single-molecule tracks (dots) within the bounds [] max min
~ , ~    determined in the 
optimization for a given value of  ~ = 0.689. The graph is using the data listed in Fig. 1. The solid green line corresponds to the average 
sub  ~  over the 32 randomly selected single-molecule tracks. 
knowing whether the underlying molecular system behaves 
in ergodic or non-ergodic ways, each measurement can be 
related to an ergodic or a non-ergodic behavior unless one is 
able to show the single-molecule fingerprint of non-
ergodicity. 
Fig. (4).  A single HeLa cell was optically sectioned by two-photon 
imaging after transfection with an Alexa488-labeled short RNA 
duplex (SQ-dsCon2) in order to visualize the geometrical dimen-
sion of the cell nucleus, i.e. its measured geometrical size. Two-
photon imaging is described elsewhere [40].  
  How does the merging of variations of single-molecule 
tracks by ensemble averaging in a sparse subpopulation un-
der broken ergodicity affect the primary observable in fluo-
rescence fluctuation spectroscopy and imaging that is ‘fluo-
rescence fluctuations’? Changes in fluorescence intensity 
reflect the time-averaged molecule number fluctuations of a 
molecular system. Here, we record the absolute number of 
molecule events X occurring in a period of T units time (infi-
nite number of periods of T units time). The events x = 1 
molecule, x = 2 molecules, etc. happen with an average de-
tection probability P per unit time. For example, we record 
the number of molecules passing  V in each of 200 different 
10-microsecond periods. The theoretical frequency was first 
derived thus [36] 
()
() () ()
()
.
! !
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1 1
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  (14)
The mean number of molecules in  V observed per period 
time is given by the total of molecules observed in a total of 
different time periods. Hence, the mean value of x happen-
ings in the observation volume  V recorded or taken over an 
infinite number of time periods denotes the mean value of 
the subpopulation of molecules and equals P·T = C. By this 
representation Eqn. (14), we have immediate access to the 
measurable value of  V N c C A m    = , where the molar 
concentration of other molecules of the same kind in the bulk 
is cm and Avogadro's number of [mol
-1] is NA. In order to 
guarantee that the Poisson probability ln{N}
ln{P(X=1,C)} = ln{P1} = lnC  C (see Eqn. (14)) of finding 
a single molecule in the femtoliter-sized observation volume 
 V= 0.14·10
-15 [L] is N < 1 [37], a cut-off at about 11 nM 
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bulk concentration is motivated for  V = 0.14 ·10
-15 [L]. For 
C e C
 << , it follows straightforwardly  C P N   1  [37]. If 
the random waiting time distributions  () t   are sampled at 
points which do not fulfill the condition N < 1, we must be 
aware of aliasing effects with terms of two, three, etc. mole-
cules at the same time in the observation volume  V = 
0.14·10
-15 [L].  
  Let us ask now how long does it take to record 32 differ-
ent single molecules of the same kind in the observation vol-
ume  V = 0.14·10
-15 [L]? The probability that the entering 
molecule is the original molecule was found to be 
N p p n n n n =  = , , 1 , where pn,n is the reentry probability for 
non-meaningful reentries [14]; if the selfsame molecule does 
not diffuse out or in the observation volume  V then there is 
a non-meaningful molecular situation and, therefore, no tem-
poral fluctuations in the fluorescence intensity traces of that 
molecule. Hence, the meaningful time Tm to observe just one 
single molecule in  V is [14] 
{} V N c V N c
T
A m A m
D
m        
=
exp
  .   (15)
D   is the diffusion time of the molecule. This is the exact 
physical solution for the time that one can study the same 
molecule within  V [14].The probability that the single ob-
servation has the given variate value X = 1 is the proportion 
of times the variate-value X = 1 turns up when a larger num-
ber (theoretically, infinity) of random selections are made. 
The proportion of times that the same single molecule turns 
up exactly equals the proportion of individual molecules in 
the subpopulation which have a variate-value X = 1, in the 
long run T. Hence, given a subpopulation of different single 
molecules of the same kind, the ratio T/Tm that a randomly 
selected molecule has a variate-value X = 1 allows to com-
pare different individual molecules 
max  N of the same kind in 
the subpopulation at the measured time-averaged molecule 
number N < 1 per observation volume  V
m T
T
N =
max    .      (16) 
We can, each time Tm we take a sample, calculate the num-
berof different single molecules of the same kind 
max  N = 32: 
which are recorded or taken over a finite longer time period 
T, by the useful and simple Eqn. (16). We found that for any 
choice at all for N < 1 there is a solution whose probability is 
given by the second and third criterion: the analytical sensi-
tivity to detect a single molecule [37] and the arrival and 
departure probability of the same single molecule [15, 38] 
(see also Fig. 48.2 in ref. [39]: Synopsis of a new physically 
grounded technology of fluorescence fluctuation spectros-
copy for observing single molecules at longer time scales 
than currently available). The corresponding discussion of 
Baumann and Földes-Papp [17] also applies here. 
 ~  is related by Eqs. (8)-(10) to anomalous diffusive mo-
tion in fluorescence correlation spectroscopy and two-color 
fluorescence crosscorrelation spectroscopy. As indicated in 
the method section, Dapp(t) is a function of the continuously 
but slowly varying network conditions  ~ , i.e.  ()   f = ~ .
We assume that the distribution of exposure to interactions 
depends on the square root of the mean square displacement. 
The  longer the diffusive path of the molecules, the 
broader the distribution of exposure to ligands (biochemical 
traps). We mean that the molecules are more frequently ex-
posed to neighboring ligands, the longer their diffusive paths 
become. This is a very reasonable assumption. The property 
of self-similarity implies that a scaling relation exists be-
tween the structure observed at one scale r and that found at 
subsequent scales. However, this is not the scaling that as-
sumes      = ~  with  1 ~ , 0 < <    is uniform but rather a 
new kind of scaling that is filled with heterogeneity . Due 
to different selectivity in the biological binding events of a 
crowded and highly heterogeneous environment like a living 
cell or body fluids like blood and its components, we choose 
the so-called Weibull distribution as the frequency distribu-
tion of exposure to interactions for molecules. 
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where m(< r) is the cumulative exposure of molecule species 
with size less than r, mtotal is the total exposure of molecule 
species, and rmax is related to their maximum size given by 
the geometrical size of the living cell or its nucleus (geomet-
rical dimension). The power q is an arbitrary constant but is 
taken to be a positive integer; q is the parameter of the distri-
bution. Because molecules have different shapes it is con-
venient to take a linear dimension r as the cube root of the 
molecule volume   r . For the total exposure to mo-
lecular complexes and species, respectively, we can write 
() () r m r m mtotal < + > =  ,    (18)
where m(>r) is the cumulative exposure of molecular com-
plexes with size greater than r. Hence, expansion according 
to McLaurin's formula yields 
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in which higher powers of ()
h q r r

max are neglected. By 
substitution (19) into the exposure-frequency distribution 
(17), we obtain   
()
q
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r
m
r m
 


 


=
<
max
 .     (20)
  Eqn. (20) reduces the Weibull distribution (17) to a 
power law for small r. The power-law scaling (20) describes 
how the property  () total m r m < of molecular exposure to 
interactions sites (complexes) depends on the scale r at 
which it is measured. We now turn to Eqs. (17) and (20). It is 
often convenient to specify a distribution with a probability 
density function (PDF). Taking the derivative of the Weibull 
relationship (17), we obtain the density function fWeibull(r), 
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In our Eqn. (21), fWeibull(r)dr is the fraction of interactions 
with size between r and r+dr. The integral of Eqn. (21) from 
r = 0 to   = r is unity because it includes all molecule in-
teraction sites. The probability density (PDF) for the power-
law distribution (20) is 
()
q
q
law power r
r
q r f
max
1 
  =  .     (22)
Assuming  0 > q , the average interaction size is determined 
by the first moment of Eqn. (22) that is 
max 1
r
q
q
r 
+
= .    (23)
The variance about this average interaction size  r  is 
() ()
2
max 2
2
1 2
r
q q
q
r 
+  +
=  .                   (24)
  In Fig. (4), the measured rmax value of the nucleus of a 
HeLa cells is 22.8 m. Taking the scale exponent  2 = q  in 
Eqn. (21), we obtain a quadratic Weibull distribution of ex-
posure to interaction sites with a mean interaction size  r  = 
15.2 m and  =
2
r   28.88 m
2 (Eqs. (23) and (24)). Thus, 
the upper limiting value of the MSD is 
2 r
 
 = 2.31·10
-10±
2.92·10
-11 [m
2]. 
  In summary, the probability to perform n steps during 
time t is denoted by () t n  , which is related to the waiting 
time distribution by the Laplace transform 
L () ( ) () () () ( ) () s s s s t
n
n       = = 1 . (25)
This probability is needed to analyze the MSD for a random 
walk on a fractal support carried out as a CTRW [41, 42]. 
The probability () t n   of the random waiting time distribu-
tions  () t   is sampled at points which fulfill the condition N
< 1 per observation volume  V and Eqn. (16). The MSD
traveled by the molecule during the time t is given by  
() () t r t r n
n
n   =

=0
2 2      ,     (26)
where  2
n r
   is the average distance traveled in n steps on the 
fractal.  2
n r
   is determined by the experimentally accessible 
condition of Eqn. (23). In our experiment Fig. (4),  2
n r
  =
2.31·10
-10± 2.92·10
-11 [m
2]. Here, we first introduce this kind 
of CTRW, which we call Limited Continuous Time Random 
Walks (LCTRW) on fractal supports. 
CONCLUSIONS 
  Anomalous diffusion behavior is an important issue es-
pecially in cellular single-molecule measurements and ways 
to precisely quantify this behavior are in high demand. Here, 
we present an approach on how to decide from a subset of 
single-molecule measurements how heterogeneous the stud-
ied system is in time. Specifically, we present an approach to 
distinguish between ergodic and non-ergodic behavior. We 
have proposed a change of the molecular behavior when 
single molecules are trapped in interactions with their neigh-
boring ligands and reaction partner(s), respectively or/and by 
conformational changes in a crowded environment. We as-
sume that spatial and temporal conditions are decoupled. 
is the spatial, molecular crowding parameter and   is the 
heterogeneous parameter of the temporal randomness. In this 
original research article, we present solutions to the problem 
how bulk egodicity behaves for subpopulations of biomac-
romolecules and in what ways, and by how much the interac-
tion network of single molecules can be rendered non-
ergodic by ensemble averaging during the measurement. We 
display the notations, introduce our definitions and report 
some general results. The complete absence of spatial ge-
ometry    is, of course, the simplest assumption [43] but 
more complicated structures have been considered in our 
models by numerical simulation on fractal supports. Differ-
ent physical situations correspond to different values of the 
experimentally accessible parameters     ~ =   with 
1 ~ , 0 < <   . The novel theory presented here offers a new 
way to understand the molecular behavior when single bio-
macromolecules are trapped in interactions with their neigh-
boring ligands and reaction partner(s), respectively, in a 
crowded environment. 
ACKNOWLEDGMENTS 
  Zeno Földes-Papp, who is the principal investigator, ac-
knowledges financial support in part from his Austrian FWF 
Science Fund collaborative research project P20454-N13, the 
Center for Commercialization of Fluorescence Technologies 
(CCFT), the University of North Texas Health Science Cen-
ter, and from the German University in Cairo, the University 
of Ulm (Germany) as well as the bwGRiD Cluster Ulm that 
is part of the high performance computing facilities of the 
Federal State of Baden-Wuerttemberg (Germany), where 
most of the very time-consuming and expensive numercial 
calculations were executed. Zeno Földes-Papp has visiting 
professorships at the CCFT and Department of Molecular 
Biology and Immunology, University of North Texas Health 
Science Center, TX 76107, USA, at ISS in Champaign, IL 
61822, USA and at the Mathematics Department of the 
German University in Cairo. 
REFERENCES 
[1]  Földes-Papp, Z.; Liao, S.-C.J.; You, T.; Terpetschnig, E.; Barbieri, 
B. Confocal fluctuation spectroscopy and imaging. Curr. Pharm. 
Biotechnol., 2010,1 1  (6), 639-653. 
[2]  Lu, H.P.; Xun, L.; Xie, X.S. Sinlge-molecule enzymatic dynamics. 
Science, 1998, 282, 1877-1882. 
[3]  Edman, L.; Földes-Papp, Z.; Wennmalm, S.; Rigler, R. The fluctu-
ating enzyme: a single molecule approach. Chem. Phys., 1999, 247,
11-22. 
[4]  Lu, H. P. Single-molecule protein interaction conformational dy-
namics. Curr. Pham. Biotechnol., 2009, 10, 522-531. 
[5]  Benkovic, S.J.; Hammes-Schiffer, S. A perspective on enzyme 
catalysis. Science, 2003, 301, 1196-1202.  
[6]  Kubo, R. The fluctuation-dissipation theorem. Rep. Progr. Phys.,
1966, 29, 255-284. Fluorescence Molecule Counting for Single-Molecule Studies  Current Pharmaceutical Biotechnology, 2011, Vol. 12, No. 5    833
[7]  Meroz, Y.; Sokolov, I.M.; Klafter, J. Subdiffusion of mixed ori-
gins: when ergodicity and nonergodicity coexist. Phys. Rev. E,
2010, 81, 010101(R). 
[8]  Magdziarz, M.; Weron, A.; Burnecki, K.; Klafter, J. Fractional 
Brownian motion versus the continuoous-time random walk: a 
simple test for subdiffusive dynamics. Phys. Rev. Lett., 2009, 103,
180602. 
[9]  Szymanski, J.; Weiss, W. Elucidating the origin of anomalous 
diffusion in crowded fluids. Phys. Rev. Lett., 2009, 103, 038102.  
[10]  Lubelski, A.; Sokolov, I.M.; Klafter, J. Nonergodicity mimics 
inhomogeneity in single particle tracking. Phys. Rev. Lett., 2008,
100, 0250602. 
[11]  Baumann, G.; Place, R.F.; Földes-Papp, Z. Meaningful interpreta-
tion of subdiffusive measurements in living cells (crowded envi-
ronment) by fluorescence fluctuation microscopy. Curr. Pharm. 
Biotechnol., 2010, 11 (5), 427-443.  
[12]  Wu, J.; Berland, K.M. Propagators and time-dependent diffusion 
coefficients for anomalous diffusion. Biophys. J., 2008, 95, 2049-
2052. 
[13]  Saxton, M.J. A biological interpretation of transient anomalous 
subdiffusion. I. Qualitative model. Biophys. J., 2007, 92,  1178-
1191. 
[14]  Földes-Papp, Z. Fluorescence fluctuation spectroscopic approaches 
to the study of a single molecule diffusing in solution and a live 
cell without systemic drift or convection: a theoretical study. Curr. 
Pharm. Biotechnol., 2007, 8, 261-273. 
[15]  Földes-Papp, Z. 'True' single-molecule molecule observations by 
fluorescence correlation spectroscopy and two-color fluorescence 
crosscorrelation spectroscopy. Exp. Mol. Pathol., 2007, 82, 147-
155. 
[16]  Földes-Papp, Z. How the molecule number is correctly quantified 
in two-color fluorescence cross-correlations spectroscopy: correc-
tions for cross-talk and quenching in experiments. Curr. Pharm. 
Biotechnol., 2005, 6, 437-444. 
[17]  Baumann, G.; Gryczynski, I.; Földes-Papp, Z. Anomalous behavior 
in length distributions of 3D random Brownian walks and meas-
ured photon count rates within observation volumes of single-
molecule trajectories in fluorescence fluctuation microscopy. Opt. 
Express, 2010, 18 (17), 17883-17896.  
[18]  Oltvai, Z.N.; Barabasi, A.L. Systems biology. Life's complexity 
pyramid. Science, 2002, 298, 763-764. 
[19]  Gavin, A.C.; Bösche, M.; Krause, R.; Grandi, P; Marzioch, M.; 
Brauer, A.; Schultz, J.; Rick, J.M.; Michon, A.M.; Cruciat, C.M.; 
Remor, M.; Höfert, C.; Schelder, M.; Brajenovic, M.; Ruffner, H.; 
Merino, A.; Klein, K.; Hudak, M.; Dickson, D.; Rudi, T.; Gnau, V.; 
Bauch, A.; Bastuck, S.; Huhse, B.; Leutwein, C.; Heurtier, M.A.; 
Copley, R.R.; Edelmann, A.; Querfurth, E.; Rybin, V.; Drewes, G.; 
Raida, M.; Bouwmeester, T.; Bork, P.; Seraphin, B.; Kuster, B.; 
Neubauer, G.; Superti-Furga, G. Functional organization of the 
yeast proteome by systematic analysis of protein complexes. Na-
ture, 2002, 415, 141-147. 
[20]  Ho, Y.; Gruhler, A.; Heilbut, A.; Bader, G.D.; Moore, L.; Adams, 
S.L.; Millar, A.; Taylor, P.; Bennett, K.; Boutilier, K.; Yang, L.; 
Wolting, C.; Donaldson, I.; Schandorff, S.; Shewnarane, J.; Vo, M.; 
Taggart, J.; Goudreault, M.; Muskat, B.; Alfarano, C.; Dewar, D.; 
Lin, Z.; Michalickova, K.; Willems, A.R.; Sassi, H.; Nielsen, P.A.; 
Rasmussen, K.J.; Andersen, J.R.; Johansen, L.E.; Hansen, L.H.; 
Jespersen, H.; Podtelejnikov, A.; Nielsen, E.; Crawford, J.; 
Poulsen, V.; Sørensen, B.D.; Matthiesen, J.; Hendrickson, R.C.; 
Gleeson, F.; Pawson, T.; Moran, M.F.; Durocher, D.; Mann, M.; 
Hogue, C.W.; Figeys, D.; M. Tyers, M. Systematic identification of 
protein complexes in Saccharomyces cerevisiae by mass spec-
trometry. Nature, 2002, 415, 180-183. 
[21]  Jeong, H.; Mason, S.P; Barabasi, A.L.; Oltvai, Z.N. Lethality and 
centrality in protein networks. Nature, 2001, 411, 41-42. 
[22]  Lueking, A.; Possling, A.; Huber, O.; Beveridge, A.; Horn, M.; 
Eickhoff, E.; Schuchardt, J.; Lehrach, H.; Cahill, D.J. A non-
redundant human protein chip for antibody screening and serum 
profiling. Mol. Cell Proteomics, 2003, 2, 1342-1349. 
[23]  von Mering, C.; Krause, R.; Snel, B.; Cornell, M.; Oliver, S.G.; 
Fields, S.; Bork, P. Comparative assessment of large-scale data sets 
of protein-protein interactions. Nature, 2002, 417, 399-403. 
[24]  Giot, L.; Bader, L.S.; Brouwer, C.; Chaudhuri, A.; Kuang, B.; Li, 
Y.; Hao, Y.L.; Ooi, C.E.; Godwin, B.; Vitols, E.; Vijayadamodar, 
G.; Pochart,P.; Machineni, H.; Welsh, M.; Kong, Y.; Zerhusen, B.; 
Malcolm, R.; Varrone, Z.; Collis, A.; Minto, M.; Burgess, S.; 
McDaniel, L.; Stimpson, E.; Spriggs, F.; Williams, J.; Neurath, K.; 
Ioime, N.; Agee, M.; Voss, E.; Furtak, K.; Renzulli, R.; Aanensen, 
N.; Carrolla, S.; Bickelhaupt, E.; Lazovatsky, Y.; DaSilva, A.; 
Zhong, J.; Stanyon, C.A.; Finley, R.L. Jr.; White, K.P.; Braverman, 
M.; Jarvie, T.; Gold, S.; Leach, M.; Knight, J.; Shimkets, R.A.;, 
M.P.; Chant, J.; Rothberg, J.M. A protein interaction map of Dro-
sophila melanogaster. Science, 2003, 302, 1727-1736. 
[25]  Huh, W.K.; Falvo, J.V.; Gerke, L.C.; Carroll, A.S.; Howson, R.W.; 
Weissman, J.S.; O'Shea, E.K. Global analysis of protein localiza-
tion in budding yeast. Nature, 2003, 425, 686-691. 
[26]  Winkler, T.; Kettling, U.; Koltermann, A.; Eigen, M. Confocal 
fluorescence coincidence analysis: an approach to ultra high-
throughput screening. Proc. Natl. Acad. Sci. USA, 1999, 96, 1375-
1378. 
[27]  Feder, T.J.; Brust-Mascher, I.; Slattery, J.P.; Baird, B.; Webb, 
W.W. Constrained diffusion or immobile fraction of cell surfaces: a 
new interpretation. Biophys. J., 1996, 70, 2767-2773. 
 [28]  Schwille, P.; Haupts, U.; Maiti, S.; Webb. W.W. Molecular dynam-
ics in living cells observed by fluorescence correlation spectros-
copy with one- and two-photon excitation. Biophys. J., 1999 , 77, 
2251-2265.  
[29]  Dix, J.A.; Verkman, A.S. Crowding effects on diffusion in solution 
and cells. Annu. Rev. Biophys., 2008, 37, 247-263. 
[30]  Niesner, R.; Gericke, K.-H. Quantitative determination of the sin-
gle-molecule detection regime in fluorescence fluctuation micros-
copy by means of photon counting histogram analysis. J. Chem. 
Phys., 2006, 124, 134704. 
[31]  Gopich, L.V. Concentration effectss in ''single-molecule" spectros-
copy. J. Phys. Chem. B, 2008, 112, 6214-6220. 
[32]  Vukojevic, V.; Papadopoulos, D.K.; Terenius, L.; Gehring, W.J.; 
Rigler, R. Quantitative study of synthetic Hox transcription factor-
DNA interactions in live cells. Proc. Natl. Acad. Sci. USA, 2010,
107, 4093-4098. 
[33]  Rigler, R. Fluorescence and single molecule analysis in cell biol-
ogy. Biochem. Biophys. Res. Commun., 2010, 396 (1), 170-175. 
[34]  Metzler, R.; Klafter, J. The random walker's guide to anomalous 
diffusion: a fractal dynamics approach. Phys. Rep., 2000, 339, 1-
77. 
[35]  Zumofen, G.; Hohlbein, J.; Huebner, C.G. Recurrence and photon 
statistics in fluorescence fluctuation spectroscopy. Phys. Rev. Lett.,
2004, 93, 260601. 
[36]  Földes-Papp, Z. A new dimension for the development of fluores-
cence-based assays in solution: from physical principles of FCS de-
tection to biological applications. Exp. Biol. Med., 2002, 227 (5), 
291-300.  
 [37]  Földes-Papp, Z. Ultrasensitive detection and identification of fluo-
rescent molecules by FCS: impact for immunobiology. Proc. Natl. 
Acad. Sci. USA, 2001 , 98 (20), 11509-11514.  
[38]  Földes-Papp, Z. What it means to measure a single molecule in a 
solution by fluorescence fluctuation spectroscopy. Exp. Mol. 
Phathol., 2006, 80, 209-218. 
[39]  Földes-Papp, Z. Viral chip technology in genomic medicine. Chap. 
48. In: Genomic and Personalized Medicine; Willard, H.F., Gins-
burg, G.S., Eds.; Academic Press: New York, 2009. Vol. 2, pp. 
538-561. 
[40]  Földes-Papp, Z.; König, K.; Studier, H.; Buckle, R.; Breuning, 
H.G.; Uchugonova, A.; Kostner, G.M. Trafficking of mature 
miRNA-122 into the nucleus of live liver cells. Curr. Pharm. Bio-
technol., 2009, 10, 569-578. 
[41]  Blumen, A.; Klafter, J.; White, B.S.; Zumofen, G. Continuous-
Time Random Walks on fractals. Phys. Rev. Lett., 1984, 53, 1301-
1304. 
[42]  Zumofen, G.; Klafter, J.; Blumen, A. Long time behavior in diffu-
sion and trapping. J. Chem. Phys., 1983, 79, 5131-5135. 
[43]  He, Y.; Burov, S.; Metzler, R.; Barkai, E. Random time-scale in-
variant diffusion and transport coefficients. Phys. Rev. E, 2008,
101, 058101. 
Received: January 29, 2011  Revised: February 23, 2011  Accepted: February 25, 2011 